• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    DIH Reports First Half Fiscal 2024 Financial Results

    2/20/24 7:00:00 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email

    NORWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today reported financial results for the six months ended September 30, 2023.

    Recent Highlights

    • Revenue of $27.3 million for the 6 months end September 30, 2023, representing growth of 57.7% over the prior year period
    • Revenue from device sales in the 6 months end September 30, 2023 increased by 73.9%
    • Publicly listed on Nasdaq Global Markets following completion of the business combination with Aurora Technology Acquisition Corp (ATAK) on February 7, 2024
    • Introduction of the Armeo®Spring Pro to the upper extremity device portfolio

    "We are very pleased with the Company's performance in the first half of Fiscal Year 2024 as we're continuing to penetrate new and existing markets, seeing strong growth momentum throughout the first two quarters after strong growth in the prior year," said Jason Chen, Chairman and CEO of DIH. "I'm excited by the significant growth opportunities ahead of us as we begin to operate as a publicly traded company; and look forward to connecting with the many valued stakeholders in DIH's mission to advance our vision for a transformative rehabilitative care model."

    First Half 2024 Financial Results

    Revenue for the six months ended September 30, 2023 increased by $10.0 million, or 57.7%, to $27.3 million from $17.3 million for the six months ended September 30, 2022. The overall increase was primarily due to a net increase in devices sold of $9.0 million, or 73.9%, which consisted of an increase in sales to third-party customers. The increase in devices revenue was driven by higher sales volume in Europe, the Americas and Asia. Services revenue represented an increase of $0.8 million, up 16.1% compared to the prior period. Other revenues represented an increase of $0.2 million, up 76.1% compared to the prior period.

    Changes in foreign currency exchange rates had a favorable impact on our combined net sales in six months ended September 30, 2023, resulting in an increase of approximately $0.7 million. This was mainly driven by fluctuations in Euro valuations throughout the period.

    Cost of sales for the six months ended September 30, 2023 increased by $7.7 million, or 109.7%, to $14.7 million from $7.0 million for the six months ended September 30, 2022. The Cost of Goods for device sales increased by $5.0 million, which is directly correlates to the increase in device sales and related margins remained relatively constant in local currency. The additional increase in cost of sales is mainly driven by an increase of $0.7 million in inventory reserve for slow moving parts as well as $2 million services parts costs.

    Selling, general and administrative expense for the six months ended September 30, 2023 increased by $1.8 million, or 15.8%, to $13.7 million from $11.8 million for the six months ended September 30, 2022. The increase was primarily due to professional service and IT costs increase of $2.5 million related to audit, legal and other professional services in preparation for the anticipated business combination with ATAK and becoming a publicly listed company, and investment in finance capacity in preparation for public company reporting obligations, and offset by decreases in bad debt allowance and overhead expenses.

    Research and development costs for the six months ended September 30, 2023 decreased by $0.1 million, or 2.4%, to $3.8 million from $3.9 million for the six months ended September 30, 2022. The decrease was primarily due to a decrease in consulting costs, research and development materials and services of $0.3 million offset by slight increase in personnel expenses of $0.2 million.

    As of September 30, 2023 DIH's cash and cash equivalents amounted to $2.0 million.

    About DIH Holding US, Inc.

    DIH stands for the vision to "Deliver Inspiration & Health" to improve the functioning of millions of people with disability and functional impairments. DIH is a global solution provider in blending innovative robotic and virtual reality ("VR") technologies with clinical integration and insights. Built through the mergers of global-leading niche technologies providers, DIH is positioning itself as a transformative total smart solutions provider and consolidator in a largely fragmented and manual-labor-driven industry.

    Caution Regarding Forward-Looking Statements 

    This press release contains certain statements which are not historical facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect to the business combination, the services offered by DIH and the markets in which it operates, and DIH's projected future results. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions provided for illustrative purposes only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; the inability of the parties to consummate the proposed business combination or the occurrence of any event, change or other circumstances that could give rise to the termination of the business combination agreement, failure to realize the anticipated benefits of the business combination, including as a result of a delay in consummating the potential transaction or difficulty in integrating the businesses of DIH; the inability to maintain the listing of the DIH's securities on Nasdaq; costs related to the proposed business combination; While DIH may elect to update these forward-looking statements at some point in the future, DIH specifically disclaims any obligation to do so.

    Investor Contact

    Greg Chodaczek

    332-895-3230

    [email protected]



     
    DIH HOLDING US, INC. AND SUBSIDIARIES

    INTERIM CONDENSED COMBINED BALANCE SHEETS

    (UNAUDITED) (in thousands)
     
      As of September 30,

    2023
      As of March 31,

    2023
     
    Assets      
    Current assets:      
    Cash and cash equivalents $1,987  $5,560 
    Restricted cash  501   415 
    Accounts receivable, net of allowances of $901 and $1,771, respectively  4,891   6,079 
    Inventories, net  8,170   6,121 
    Promissory note - related party  405   — 
    Due from related party  119   7,400 
    Other current assets  5,611   5,210 
    Total current assets  21,684   30,785 
    Property, and equipment, net  632   826 
    Capitalized software, net  2,293   2,203 
    Other intangible assets, net  380   380 
    Operating lease, right-of-use assets, net  4,887   3,200 
    Deferred tax assets  —   1 
    Other assets  46   39 
    Total assets $29,922  $37,434 
    Liabilities and Equity (Deficit)      
    Current liabilities:      
    Accounts payable $5,638  $3,200 
    Employee compensation  3,684   3,678 
    Due to related party  —   7,322 
    Current maturities of long-term debt  1,472   1,514 
    Revolving credit facilities  10,931   12,976 
    Current portion of deferred revenue  8,992   9,374 
    Current portion of long-term operating lease  1,675   1,255 
    Advance payments from customers  9,918   6,878 
    Accrued expenses and other current liabilities  12,692   12,411 
    Total current liabilities  55,002   58,608 
    Long-term debt, net of current maturities  —   489 
    Non-current deferred revenues  3,906   2,282 
    Long-term operating lease  3,238   1,970 
    Deferred tax liabilities  409   391 
    Other non-current liabilities  3,281   2,748 
    Total liabilities $65,836  $66,488 
    Commitments and contingencies (Note 15)      
    Equity (Deficit):      
    Net parent company investment  (39,093)  (32,977)
    Accumulated other comprehensive income  3,179   3,923 
    Total (deficit) $(35,914) $(29,054)
    Total liabilities and (deficit) $29,922  $37,434 


    See accompanying notes to the condensed combined financial statements.
     



    DIH HOLDING US, INC. AND SUBSIDIARIES

    INTERIM CONDENSED COMBINED STATEMENTS OF OPERATIONS

    (UNAUDITED) (in thousands)
     
      For the Six Months Ended September 30,
      2023   2022 
    Revenue $27,314   $17,325 
    Cost of sales  14,736    7,028 
            
    Gross profit  12,578    10,297 
    Operating expenses:       
    Selling, general, and administrative expense  13,713    11,837 
    Research and development  3,763    3,857 
    Total operating expenses  17,476    15,694 
    Operating loss  (4,898)   (5,397)
    Other income (expense):       
    Interest expense  (500)   (411)
    Other income (expense), net  (430)   325 
    Total other income (expense)  (930)   (86)
    Loss before income taxes  (5,828)   (5,483)
    Income tax expense (benefit)  278    (34)
    Net loss $(6,106)  $(5,449)


    See accompanying notes to the condensed combined financial statements.



     
    DIH HOLDING US, INC. AND SUBSIDIARIES

    INTERIM CONDENSED COMBINED STATEMENTS OF COMPREHENSIVE LOSS

    (UNAUDITED) (in thousands)
     
      For the Six Months Ended September 30, 
      2023 2022 
    Net loss $(6,106) $(5,449)
    Other comprehensive (loss) income, net of tax:      
    Foreign currency translation adjustments  (314)  1,486 
    Pension liability adjustments  (430)  (226)
    Other comprehensive (loss) income  (744)  1,260 
    Comprehensive loss $(6,850) $(4,189)


    See accompanying notes to the condensed combined financial statements.



     
    DIH HOLDING US, INC. AND SUBSIDIARIES

    INTERIM CONDENSED COMBINED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

    (UNAUDITED) (in thousands)
     
      Net Parent

    Company

    Investment
      Accumulated

    Other

    Comprehensive

    Income (Loss)
       Total Equity

    (Deficit)
     
    Balance, March 31, 2022 $(30,503) $4,081   $(26,422)
    Net loss  (5,449)  -    (5,449)
    Other comprehensive income, net of tax  -   1,260    1,260 
    Net transactions with parent  (4)  -    (4)
    Balance, September 30, 2022 $(35,956) $5,341   $(30,615)
               
      Net Parent

    Company

    Investment
      Accumulated

    Other

    Comprehensive

    Income (Loss)
       Total Equity

    (Deficit)
     
    Balance, March 31, 2023 $(32,977) $3,923   $(29,054)
    Net loss  (6,106)  -     (6,106)
    Other comprehensive loss, net of tax  -   (744)    (744)
    Net transactions with parent  (10)  -    (10)
    Balance, September 30, 2023 $(39,093) $3,179   $(35,914)


    See accompanying notes to the condensed combined financial statements.



     
    DIH HOLDING US, INC. AND SUBSIDIARIES

    INTERIM CONDENSED COMBINED STATEMENTS OF CASH FLOWS

    (UNAUDITED) (in thousands)
     
      For the Six Months Ended September 30, 
      2023  2022 
    Cash flows from operating activities:      
    Net loss $(6,106) $(5,449)
    Adjustments to reconcile net loss to net cash provided by operating activities:      
    Depreciation and amortization  211   235 
    Allowance for doubtful accounts  (870)  97 
    Allowance for inventory obsolescence  708   (121)
    Gain on disposal of fixed assets  -   (3)
    Pension contributions  (324)  (296)
    Pension (income) expense  136   (245)
    Foreign exchange (gain) loss  428   (320)
    Noncash lease expense  1,000   935 
    Noncash interest expense  2   68 
    Deferred income tax  12   (89)
    Changes in operating assets and liabilities:     - 
    Accounts receivable  2,004   1,996 
    Inventories  (2,470)  (1,568)
    Due from related parties  -   (60)
    Due to related parties  -   (1)
    Other assets  (150)  (916)
    Operating lease liabilities  (898)  (798)
    Accounts payable  1,840   754 
    Employee compensation  (81)  316 
    Other liabilities  74   424 
    Deferred revenue  1,604   206 
    Advance payments from customers  2,992   7,847 
    Accrued expense and other current liabilities  (2)  735 
    Net cash provided by operating activities  110   3,747 
    Cash flows from investing activities:      
    Purchases of property and equipment  (49)  (15)
    Proceeds from sale of property and equipment  62   - 
    Payments to related party for promissory note  (405)  - 
    Net cash used in investing activities  (392)  (15)
    Cash flows from financing activities:      
    Payments on credit facilities  (2,679)  (1,462)
    Payments on long term debt  (625)  (465)
    Net cash used in financing activities  (3,304)  (1,927)
    Effect of currency translation on cash and cash equivalents  99   (262)
    Net decrease in cash, and cash equivalents, and restricted cash  (3,487)  1,543 
    Cash, and cash equivalents, and restricted cash - beginning of year  5,975   3,687 
    Cash, and cash equivalents, and restricted cash - end of year $2,488  $5,230 
    Cash and cash equivalents - end of year $1,987  $4,832 
    Restricted cash - end of year  501   398 
    Total cash, and cash equivalents, and restricted cash - end of year $2,488  $5,230 
    Supplemental disclosure of cash flow information:      
      Interest paid $498  $346 
    Supplemental disclosure of non-cash investing and financing activity:      
      Settlement of related party receivables and payables $7,322  $- 


    See accompanying notes to the condensed combined financial statements.





    Primary Logo

    Get the next $DHAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    SEC Filings

    View All

    DIH Holdings US Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    11/26/25 9:32:54 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holdings US Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Unregistered Sales of Equity Securities

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    11/6/25 6:03:40 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holdings US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    10/21/25 4:45:55 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DIH Announces Fiscal 2025 Fourth Quarter and Fiscal Year End Financial Results

    NORWELL, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the fiscal 2025 fourth quarter and fiscal year ended March 31, 2025. Recent Highlights Revenue of $62.9 million for the fiscal year ended March 31, 2025, representing a decrease of 2.5% over the prior year Device revenue of $49.7

    10/20/25 5:05:09 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holding US, Inc. Announces Reverse Stock Split of its Series A Common Stock

    NORWELL, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) today announced that it will implement a reverse stock split of its Class A Common Stock, par value $0.0001 per share (the "Common Stock"), at a ratio of 1-for-25 (the "Reverse Stock Split"). The Reverse Stock Split was approved by the Company's stockholders at the Company's Special Meeting of Stockholders held on September 25, 2025, with the final ratio subsequently determined by the Company's Board of Directors on September 26, 2025. The Reverse Stock Split will take effect at market open on October 20, 2025, and the Common Stock will trade on a post-split basis on the Nasdaq Sto

    10/16/25 8:00:00 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holding US, Inc. Clarifies Previous Disclosure Regarding Additional Nasdaq Staff Determination Letter

    NORWELL, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- On September 18, 2025, DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) issued a press release disclosing that it had received a notice on September 12, 2025, from the Listing Qualifications Staff ("Staff") of the Nasdaq Stock Market LLC ("Nasdaq") that it had failed to regain compliance under Nasdaq Listing Rule 5450(b)(2)(A) (the "Bid Price Rule"), so this matter was an additional basis for delisting. The Company is clarifying that since it was not current in filing its Form 10-Q for the period ended June 30, 2025, and Form 10-K for the fiscal year ended March 31, 2025 under Nasdaq Listing Rule 5250(c)(1) (the "Reports Rule"),

    10/1/25 8:11:40 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Mooney Barrett claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    9/8/25 5:15:27 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Burell Scott R claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    8/11/25 4:05:17 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Streppa Dennis claimed ownership of 78,022 shares (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    7/25/25 4:30:13 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    View All

    DIH Announces Fiscal 2025 Fourth Quarter and Fiscal Year End Financial Results

    NORWELL, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the fiscal 2025 fourth quarter and fiscal year ended March 31, 2025. Recent Highlights Revenue of $62.9 million for the fiscal year ended March 31, 2025, representing a decrease of 2.5% over the prior year Device revenue of $49.7

    10/20/25 5:05:09 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Barrett Mooney, Ph.D. to its Board of Directors. Barrett Mooney, Ph.D., has an extensive track record of growing complex and manufacturing related businesses. He currently provides strategic advisory services to growing high-technology private and public compan

    9/8/25 4:46:27 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors. Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financia

    8/8/25 8:00:00 AM ET
    $DHAI
    $MBOT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 6:07:49 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 12:46:18 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by DIH Holdings US Inc.

    SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

    2/20/24 5:18:47 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care